Solventum has appointed former Zimmer Biomet executive Rachel Ellingson as chief strategy and corporate development officer.
Morgan Stanley analyst Patrick Wood maintained a Hold rating on Solventum Corporation (SOLV – Research Report) today and set a price target of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback